Page 70 - Traité de chimie thérapeutique 6 Médicaments antitumoraux
P. 70

26                         GENERALITES SUR LES MÉDICAMENTS ANTTTUMORAUX

             PETERS R.T., MANIATIS T., A new family of IKK-related kinases may function as 1KB
               kinase kinases, Biochim. Biophys. Acta, 2001, 1471, M57-M62.
             PRESTON T.J. et al., Mitochondrial contributions to cancer cell physiology : potential for
               drug development, Adv. Drug Deliv. Rev., 2001, 49, 45-61.
             WEBER C.H., VINCENZ C., The death domain superfamily : a tale of two interfaces ?
               Trends Biochem. Sci., 2001, 26, 475-481.
              ADAMS J., Proteasome inhibition: a novel approach to cancer therapy, Trends Mol.
               Med., 2002, 8, S49-S54.
              DE BONO J.S., ROWINSKY E.K., The ErbB receptor family : a therapeutic target for
               cancer, Trends Mol. Med., 2002, 8, S19-S26.
              DUNN C. et al., Molecular mechanism and biological functions of c-Jun N-terminal
                kinase signalling via the c-Jun transcription factor, Ce//. Signalling, 2002, 14, 585-593.
              FRAME M.C., Src in cancer : deregulation and consequences forcell behaviour, Biochim.
                Biophys. Acta, 2002, 1602, 114-130.
              GILMORE T. et al., Rel/NF-xB/IxB signal transduction in the generation and treatment of
                human cancer, Cancer Lett., 2002, 181, 1-9.
              KANEKURA T. et al., The involvement of NF-xB in the constitutive overexpression of
                cyclooxygenase-2 in cyclooxygenase-1 null cells, Biochim. Biophys. Acta, 2002,
                1542, 14-22.
              MAZURE N.M. et al., Repression of a-fetoprotein gene expression under hypoxie con-
                ditions in human hepatoma cells : characterization of a negative hypoxia response
                element that mediates opposite effects of hypoxia inducible factor-1 and c-myc, Can-
                cer Res., 2002, 62, 1158-1165.
              NICHOLSON K. M., ANDERSON A.N.G., The protein kinase B/Akt signalling pathway in
                human malignancy, Ce//. Signalling, 2002, 14, 381-395.
              NISHI H. et al., Early growth response-1 gene mediates up-regulation of epidermal
                growth factor receptor expression during hypoxia, Cancer Res., 2002, 62, 827-834.
              NZEAKO U.C. et al., COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma
                cells, Hepatology (Baltimore, MD), 2002, 35, 552-559.
              WASHO-STULTZ D. et al., Role of mitochondrial complexes I and Il, reactive oxygen
                species and arachidonic acid metabolism in deoxycholate-induced apoptosis, Cancer
                Lett., 2002, 177, 129-144.
               ZWICK E. et al., Receptor tyrosine kinases as targets for anticancer drugs, Trends Mol.
                Med., 2002, 8, 17-23.
   65   66   67   68   69   70   71   72   73   74   75